Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
G1 Therapeutics Inc (GTHX)
NASDAQ:GTHX
Holding GTHX?
Track your performance easily
G1 Therapeutics (GTHX) Ownership Overview
27.31% Insiders
14.58% Mutual Funds
21.15% Other Institutional Investors
― ETFs
36.96% Public Companies and
Individual Investors
The ownership structure of G1 Therapeutics (GTHX) stock is a mix of institutional, retail, and individual investors. , 27.31% is owned by Insiders, and 36.96% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 08, 2024 | xxxxxxxxxxxxx | $1318 | |
| Jul 08, 2024 | xxxxxxxxxxxxx | $6188 | |
| Jul 08, 2024 | Andrew Perry Cco | xxxxxxxxxxxxx | $3343 |
| Jul 08, 2024 | John E. (jack) Jr. Bailey President & Ceo,director | xxxxxxxxxxxxx | $19155 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $125897 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $3106167 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,290,653 | Institution | 6.10% | 16,378,169 | |
| 2,045,469 | Institution | 5.44% | 14,625,103 | |
| 1,362,354 | Institution | 3.63% | 9,740,831 | |
| 1,233,467 | Institution | 3.28% | 8,819,289 | |
| 513,118 | Institution | 1.37% | 3,668,794 | |
| 449,736 | Institution | 1.20% | 3,215,612 | |
| 398,043 | Institution | 1.06% | 2,846,007 | |
| 205,903 | Institution | 0.55% | 1,472,206 | |
| 176,609 | Institution | 0.47% | 1,262,754 | |
| 113,773 | Institution | 0.30% | 813,477 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,045,469 | Institution | 5.44% | 14,625,103 | |
| 1,233,467 | Institution | 3.28% | 8,819,289 | |
| 513,118 | Institution | 1.37% | 3,668,794 | |
| 449,736 | Institution | 1.20% | 3,215,612 | |
| 398,043 | Institution | 1.06% | 2,846,007 | |
| 205,903 | Institution | 0.55% | 1,472,206 | |
| 176,609 | Institution | 0.47% | 1,262,754 | |
| 113,773 | Institution | 0.30% | 813,477 | |
| 105,000 | Institution | 0.28% | 750,750 | |
| 87,233 | Institution | 0.23% | 623,716 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,386,934 | Institution | 3.69% | 5,949,947 | |
| 658,535 | Institution | 1.75% | 2,825,115 | |
| 193,708 | Institution | 0.52% | 831,007 | |
| 47,348 | Institution | 0.13% | 203,123 | |
| 4,128 | Institution | 0.01% | 17,709 | |
| 139 | Institution | <0.01% | 348 |
FAQ
Who Owns G1 Therapeutics Inc (GTHX)?
According to the latest TipRanks data, approximately 21.15% of the company's stock is held by institutional investors, 27.31% is held by insiders, and 36.96% is held by retail investors.
What percentage of G1 Therapeutics Inc (GTHX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 21.15% of G1 Therapeutics Inc (GTHX) stock is held by institutional investors.
What percentage of G1 Therapeutics Inc (GTHX) stock is held by retail investors?
According to the latest TipRanks data, approximately 36.96% of G1 Therapeutics Inc (GTHX) stock is held by retail investors.
Who owns the most shares of G1 Therapeutics Inc (GTHX)?
Vanguard owns the most shares of G1 Therapeutics Inc (GTHX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.